Trial · NCT02701296
Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty
NCT02701296, Not applicable, Completed, Trinity Health Of New England; results first posted 2017-06-14
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty. Trials, record NCT02701296. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02701296
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty
- NCT number
- NCT02701296
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 80 participants, actual
- Lead sponsor
- Trinity Health Of New England
- Conditions
- Posterior Knee Infiltration
- Interventions
- Ropivacaine with Epinephrine, Ropivacaine
- First posted
- 2016-03-08
- Last updated
- 2018-10-03
- Results first posted
- 2017-06-14
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain Intensity | 48 hours post surgery | Mean Numeric Pain Rating Scale (NPRS) self-reported pain Intensity on a 11-point score (0=no pain to 10= worst possible) in Post Anesthesia Care Unit (PACU) and every 6 hours for 48 hours post surgery |
| Secondary | Opioid Consumption | 24 hours post surgery | Amount of opioid used for the first 24 hours post surgery |
| Secondary | Plantar Flexion in the Tibial Nerve Distribution | Upon emergence from anesthesia in the PACU | Blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block) |
| Secondary | Cold Sensation in the Tibial Nerve Distribution | Upon emergence from anesthesia in the PACU | Number of participants with a self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block) |
| Secondary | Dorsiflexion in the Peroneal Nerve Distribution | Upon emergence from anesthesia in the PACU | Number of participants with a blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block) |
| Secondary | Sensation in the Peroneal Nerve Distribution | Upon emergence from anesthesia in the PACU | Number of participants with self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block) |
Source ClinicalTrials.gov
Outcomes6
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pain Intensity | 48 hours post surgery | pain score | MEAN | |
| SECONDARY | Opioid Consumption | 24 hours post surgery | Mean consumption of Hydromorphone(mg) post-op day 1 | mg | MEAN |
| SECONDARY | Plantar Flexion in the Tibial Nerve Distribution | Upon emergence from anesthesia in the PACU | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Cold Sensation in the Tibial Nerve Distribution | Upon emergence from anesthesia in the PACU | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Dorsiflexion in the Peroneal Nerve Distribution | Upon emergence from anesthesia in the PACU | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Sensation in the Peroneal Nerve Distribution | Upon emergence from anesthesia in the PACU | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Pain Intensity | Posterior Capsular Injection | PACU Admission | 3.5 | Standard Deviation 2.95 | pain score |
| Pain Intensity | Tibial Nerve Block | PACU Admission | 3.2 | Standard Deviation 3.67 | pain score |
| Pain Intensity | Posterior Capsular Injection | PACU Discharge | 2.1 | Standard Deviation 1.78 | pain score |
| Pain Intensity | Tibial Nerve Block | PACU Discharge | 1.5 | Standard Deviation 1.73 | pain score |
| Pain Intensity | Posterior Capsular Injection | 6th hour | 1.9 | Standard Deviation 1.85 | pain score |
| Pain Intensity | Tibial Nerve Block | 6th hour | 2.0 | Standard Deviation 2.17 | pain score |
| Pain Intensity | Posterior Capsular Injection | 12th hour | 2.0 | Standard Deviation 2.36 | pain score |
| Pain Intensity | Tibial Nerve Block | 12th hour | 1.2 | Standard Deviation 2.03 | pain score |
| Pain Intensity | Posterior Capsular Injection | 18th hour | 2.3 | Standard Deviation 2.21 | pain score |
| Pain Intensity | Tibial Nerve Block | 18th hour | 3.2 | Standard Deviation 2.36 | pain score |
1 to 10 of 46Source ClinicalTrials.gov
See all 46 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Posterior Capsular Injection | 42 | |
| Overall Study | STARTED | Tibial Nerve Block | 38 | |
| Overall Study | COMPLETED | Posterior Capsular Injection | 42 | |
| Overall Study | COMPLETED | Tibial Nerve Block | 36 | |
| Overall Study | NOT COMPLETED | Posterior Capsular Injection | 0 | |
| Overall Study | NOT COMPLETED | Tibial Nerve Block | 2 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Posterior Capsular Injection | 0 | 42 |
| Total, all-cause mortality | Tibial Nerve Block | 0 | 36 |
| Total, other adverse events | Posterior Capsular Injection | 0 | 42 |
| Total, other adverse events | Tibial Nerve Block | 0 | 36 |
| Total, serious adverse events | Posterior Capsular Injection | 0 | 42 |
| Total, serious adverse events | Tibial Nerve Block | 0 | 36 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Posterior Capsular Injection vs Tibial Nerve Block: deaths from any cause | Trial comparisons |
| Posterior Capsular Injection vs Tibial Nerve Block: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02701296
GET https://conductscience.org/api/trials/v1/NCT02701296/results?page=2